Schedule 7 Requires a Substance to Be Harmful, Addictive, and Without Medical Use
SAHPRA classifies psilocybin as Schedule 7 — alongside heroin and fentanyl. That classification requires three criteria. Psilocybin fails all three.
"Harmful"
Professor David Nutt describes psilocybin as among the safest drugs known to science. Extremely low toxicity. Virtually no risk of lethal overdose.
"Dependence-Producing"
Animal and human research confirm psilocybin is not addictive. Described as "anti-addictive" — actively used to treat nicotine and alcohol addiction.
"No Medical Use"
Clinical trials at Johns Hopkins and Imperial College London show sustained efficacy for depression, PTSD, anxiety, and addiction. Australia approved prescription use in 2023.